Receptors, Fibroblast Growth Factor, antagonists & inhibitors
- Name
- Receptors, Fibroblast Growth Factor, antagonists & inhibitors
- Accession Number
- DBCAT002854
- Description
Not Available
- Drugs
Drug Drug Description LY-2874455 LY2874455 has been used in trials studying the treatment of Advanced Cancer. Erdafitinib A fibroblast growth factor receptor tyrosine kinase inhibitor used to treat locally advanced or metastatic urothelial carcinoma. Pemigatinib A kinase inhibitor used to treat locally advanced or metastatic, unresectable cholangiocarcinoma in previously treated adult patients. Infigratinib An FGFR inhibitor used to treat locally advanced or metastatic cholangiocarcinoma in adults with a fibroblast growth factor receptor 2 (FGFR2) rearrangement. - Drugs & Drug Targets